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Background: The venom of Centruroides limpidus limpidus (Cll) is a mixture of pharmacologically active principles.
The most important of these are toxic proteins that interact both selectively and specifically with different cellular
targets such as ion channels. Recently, anticancer properties of the venom from other scorpion species have been
described. Studies in vitro have shown that scorpion venom induces cell death, inhibits proliferation and triggers
the apoptotic pathway in different cancer cell lines. Herein, after treating human cervical adenocarcinoma (HeLa)
cells with Cll crude venom, their cytotoxic activity and apoptosis induction were assessed.
Results: Cll crude venom induced cell death in normal macrophages in a dose-dependent manner. However,
through viability assays, HeLa cells showed high survival rates after exposure to Cll venom. Also, Cll venom did not
induce apoptosis after performing ethidium bromide/acridine orange assays, nor was there any evidence of
chromatin condensation or DNA fragmentation.
Conclusions: Crude Cll venom exposure was not detrimental to HeLa cell cultures. This may be partially
attributable to the absence of specific HeLa cell membrane targets for molecules present in the venom of
Centruroides limpidus limpidus. Although these results might discourage additional studies exploring the potential of
Cll venom to treat human papilloma cervical cancer, further research is required to explore positive effects of crude
Cll venom on other cancer cell lines.
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Scorpions and their venom have been used for centuries
as medical treatments in traditional medicine in India,
China, Africa and Cuba [1]. Scorpion venom has been
used to treat pain, epilepsy, tetanus, subcutaneous
nodules, and cancer [2-5]. It has been suggested that such
properties may be partially explained by the presence of a
variety of pharmacologically active substances, such as
amino acids, inorganic salts, nucleotides, biogenic amines,
lipids, enzymes and toxic proteins [6,7].
Despite huge efforts to find a cure for cancer, current
treatments such as surgery, chemotherapy and radiotherapy* Correspondence: abarbabosa@yahoo.com.mx
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distribution, and reproduction in any mediumstill have not achieved satisfactory levels of protection or re-
mission [1]. Moreover, existing treatments cause undesir-
able side effects and damage to healthy tissue surrounding
tumors in patients under treatment [8]. Furthermore, it has
been shown that tumor cells can develop resistance to
some therapies [9].
Recently, it has been reported that some scorpion
venoms inhibit the growth of various cancer cell lines via
three distinct mechanisms: blocking specific ion channels,
specifically binding to cancer cell membrane proteins,
impairing their ability to invade, and activating intracellu-
lar pathways of apoptosis [10-13].
Cytotoxic, antiproliferative and apoptogenic effects
have been demonstrated in vitro, by using crude venom
of different scorpion species. MCF-7 (breast cancer) and
SH-SY5Y (human neuroblastoma) cell lines treated withCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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increased production of nitric oxide (NO) and reactive
nitrogen intermediates (RNI), which are molecules re-
lated to mitochondrial depolarization and activation of
caspase-3, present in apoptosis [14,15]. Rophalurus
junceus venom exhibited remarkable cytotoxic effects in
a non-dose-dependent manner on the mouse myeloma
cell line P3-X63 [16]. The venom of Heterometrus
bengalensis showed antiproliferative and apoptosis-
inducing properties on U937 and K562 human leukemia
cell lines, where chromatin condensation and DNA
fragmentation were observed [3]. Additionally, Buthus
martensi venom induced cell death by apoptosis, redu-
cing the growth of U251-MG glioma cells probably by
inhibition and modulation of several ion channels [17].
The anticancer therapeutic potential of the venoms
from the several existent Mexican scorpion species has
not been studied in detail. Considering the evolutionary
relationship among scorpion species whose venoms
have shown activity against cancer cell lines, we tested
the hypothesis that Centruroides limpidus limpidus
(Cll) venom produces therapeutic effects against cancer
cells. In the present work, we evaluated the apoptotic
and cytotoxic properties of Cll crude venom on human
cervical adenocarcinoma (HeLa) cells.Methods
Venom source
Centruroides limpidus limpidus specimens were col-
lected in the municipality of Pilcaya, Guerrero, Mexico
and transported to the animal housing facility of the
Center for Research and Advanced Studies in Animal
Health (Centro de Investigación y Estudios Avanzados
en Salud Animal), from the School of Veterinary
Medicine and Zootechny (Facultad de Medicina
Veterinaria y Zootecnia), Autonomous University of
Mexico State (Universidad Autónoma del Estado de
México). C. limpidus limpidus were phenotypically iden-
tified at the species level with the use of keys, fed ad
libitum and reared under standard insectary conditions
(25°C, 75% RH) [18].Venom collection and preparation
The venom of 50 scorpions was obtained by electrical
stimulation (10–20 V) of the telson, diluted in 500 μL of
double distilled water, centrifuged at 14000 × g for ten
minutes at 4°C, after which the supernatant was
recovered [19]. Protein concentration was determined
using the Bradford assay (BioRad, USA) and absorption
was read at 595 nm. For cytotoxicity assays, the venom
was used immediately after collection. To test bioactivity
in mice, the venom was aliquoted and stored at −80°C
until further use [10].Venom bioactivity test
To determine the bioactivity of Cll venom after collection,
Balb/c mice (18 g, four weeks old, n = 9) were intramuscu-
larly inoculated with 100 μL of 2.27 μg/μL of diluted crude
venom. A control group (CTRL–) was injected with 100
μL of sterile, double-distilled water. The time of death and
symptoms after inoculation were recorded. Experimental
protocols were conducted according to the guidelines of
the Bioethics Committee of the UAEM-FMVZ, the
Official Mexican Standard (or Norma Oficial Mexicana –
NOM-0062-ZOO-1999) technical specifications for the
care and use of laboratory animals, as well as international
standards [20,21].
Cell culture
HeLa cells (ATCC: CCL-2) were grown to confluence in
T25 flasks (Sarstedt, USA) with DMEM (Gibco Labora-
tories, USA) at 37°C, 5% CO2, 10% fetal bovine serum
(FBS; Atlanta Biologicals, USA) and 1% penicillin-
streptomycin (Gibco Laboratories, NY). Cell culture pas-
sages were performed by trypsinization when confluence
reached 90% according to published protocols [22,23].
Briefly, the medium was removed and the confluent
monolayer cells were washed with PBS (Gibco-BRL,
USA); then cells were incubated with 1 mL of 0.25%
trypsin (Gibco-BRL, USA) and further incubated for
three minutes. Cells were then resuspended by pipetting,
transferred to 15 mL conical tubes and centrifuged at
300 × g for five minutes. The supernatant was then
discarded and cells were resuspended in DMEM 10%
FBS. Cells were counted with a hemocytometer and via-
bility was determined using Trypan blue [24].
Cytotoxicity and viability (MTS) assays
Ten thousand cells were kept in 96 well plates for 24
hours in 10% FBS-supplemented DMEM. Then, the
medium was replaced with 100 μL of MFS (FBS-free
DMEM), after which four different doses of venom (50,
100, 200 and 400 μg/100 μL per well) were tested.
Cyclophosphamide (Genoxal® Baxter Oncology, 400 μg/
100 μL of medium) was used as positive control (CFF)
and untreated cells as negative control (CTRL–). Three
replicates per treatment were conducted. After incuba-
tion, the number of viable cells was estimated through a
commercial MTS colorimetric assay (CellTiter 96®
Aqueous One Solution kit, Promega, USA) according to
the manufacturer’s instructions. Colorimetric reactions
were measured with a spectrophotometer (Epoch, serial
number 1209284) at 490 nm.
Macrophage culture
To evaluate the effect of Cll venom on physiologically
normal cells, venom toxicity in Balb/c adult mouse mac-
rophages was tested. Animals were intraperitoneally
Figure 1 Venom bioactivity at different days post-collection
differed statistically (p < 0.05) in four-week-old Balb/c mice
among treatments despite a lower bioactivity tendency found
in venom 8 days post-collection.
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later, the mice were killed humanely and cells were
harvested by peritoneal lavage [25]. Briefly, the periton-
eal cavity was injected with 5 mL of cold RPMI-1640
(Invitrogen, USA) and lightly massaged. The injected
fluid was then aspirated and centrifuged for three
minutes at 300 × g. Recovered cells were centrifuged
and then washed three times (300 × g for three minutes,
PBS). Washed cells were then inoculated into a 96-well
plate at 1 × 106 cells/well in 10% FBS-supplemented
RPMI-1640. After incubation at 37°C for two hours in
5% CO2, the plate was washed twice with RPMI-1640 to
remove non-adherent cells [26]. Adhered macrophages
were exposed to 0 (CTR–), 50, 100 or 400 μg/100 μL of
crude Cll venom in RPMI-1640 MFS. After a 24-hour
incubation period, cell viability was determined
according to the previous description.
Apoptosis
To determine whether dying cells had undergone apop-
tosis, the ethidium bromide/acridine orange (EB-AO)
staining method was adapted for the 96-well plate [24,27].
Briefly, 104 cells/well were seeded in a 96 flat-bottomed
well microtiter plate (Sarstedt, USA) containing 10% FBS-
supplemented DMEM and incubated under controlled
conditions (37°C and 5% CO2). After a 24-hour incubation
period, the medium was replaced with 100 μL of fresh
MFS, containing different venom concentrations, and
further incubated for 24 hours. Then, the plate was
centrifuged at 129 × g for five minutes and 8 μL of EB-AO
was added to each well. Cells were observed under 40×
magnification to search for typical apoptosis-induced
morphological changes, such as apoptotic vesicles and
chromatin condensation. Images of the cells were obtained
with a Leica DMIL inverted fluorescence microscope
equipped with a Nikon Coolpix S2500 digital camera.
Results
Venom bioactivity
The mice inoculated with 100 μL of crude Cll venom at
2.27 μg/μL displayed ataxia, nasal pruritus, piloerection,
tachypnea, tremor, seizures and excitability. As the time
from venom collection to inoculation increased, venom-
challenged individuals displayed longer survival, which
suggests time-dependent venom degradation and loss of
bioactivity after collection (Figure 1).
Cell morphology
HeLa cells were monitored 24 hours after exposure to
50, 100, 200 or 400 μg/100 μL of crude Cll venom.
Treated cells did not show morphological changes, while
the monolayer remained attached to the bottom of the
plate. There was no evidence of membrane rupture or
release of cytosolic contents in the culture medium andno morphological changes were apparent when com-
pared to control cells (Figure 2A and B).
Cell viability (MTS)
HeLa cells treated with doses ranging from 50–400 μg/
100 μL of crude Cll venom showed viability of nearly
100%. However, cells treated with cyclophosphamide
displayed ~80% mortality (Figure 3). In contrast, the
same treatment induced cell death in Balb/c mice mac-
rophages in a dose-dependent manner. Cell death was
determined by evidence of necrosis (Figure 4).
Apoptotic and necrotic effects
Crude Cll venom cytotoxicity was also explored by
assessing apoptosis. Post-venom-treated HeLa cells (24
hours) did not display typical apoptotic signs, such as
nuclear condensation or DNA fragmentation (Figure 5A).
Observation of intact nuclei also suggested lack of necrosis.
However, cyclophosphamide-treated HeLa cells (positive
control) showed typical apoptotic features such as chroma-
tin condensation, monolayer loss, detachment from the
plate, and cell shrinkage (Figure 5B).
Discussion
It has been previously shown that exposure of several
cancer cell lines to scorpion venoms induces major
changes in cell morphology, loss of cell monolayers, cell
contraction and death by either apoptosis or necrosis
[14-17]. Our results showed that crude Cll venom-
treated HeLa cells did not display any of the toxic effects
produced by other scorpion species venom and cancer
cell lines.
To find out whether bioactivity was lost after collec-
tion in a time-dependent manner, this parameter was
evaluated at different time points after collection. Mice
Figure 2 Morphology of HeLa cells 24 hours after incubation with MFS: only one dose is shown since no differences were observed
among different doses. (A) Venom dose of 400 μg/100 μL and (B) untreated control cells.
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expected features of scorpionism, although onset of
symptoms and death occurred within a shorter time
[25]. This acceleration might be due to the fact that mice
were challenged with a concentration higher than the
lethal dose calculated for Cll (unpublished data).
Although its bioactivity was reduced over time, mice
mortality confirmed that venom remained bioactive even
several days after collection (Figure 1).Figure 3 MTS metabolism in Hela cells after treatment with
different doses of venom (50-400 μg/100 μL of medium),
positive control (CFF, cyclophosphamide 400 μg/100 μL) and
negative control (CTRL–). Optical density (OD) was read at 490 nm,
the data were plotted according to the mean and SD. Treatment
means differed significantly with respect to the positive control but
not for the negative control (p < 0.05).MTS metabolism assays detected no venom-related
effects on the viability of HeLa cells (Figure 3). These
results contrast with what has been reported by others,
specifically regarding the effects of crude venom of dif-
ferent scorpion species on several cancer cell lines,
where cell viability is affected in a dose-dependent
manner [4,14,15]. However, we found that crude Cll
venom was toxic to Balb/c mice macrophages, as previ-
ously described in a Tityus serrulatus scorpion venom
challenge of Balb/c mice macrophages [28]. Interestingly,
Cll venom-induced macrophage mortality at 50 μg/mLFigure 4 MTS metabolism by macrophages and viability
percentage showed significant difference between treatment
means at p < 0.05.
Figure 5 Images showing Hela cells after treatment with scorpion venom. (A) Cells treated with scorpion venom up to 400 μg/100 μL, and
(B) positive controls showing apoptotic cells treated with cyclophosphamide (400 μg/100 μL).
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in T. serrulatus (5%).
Prior studies on the effect of arachnid venom and
cytotoxicity on HeLa cells contrasted with our results.
The venom of Macrotele raven, which induced cell death
by apoptosis and cytotoxicity, was diluted in PBS [29].
Interestingly, cells incubated in PBS for 24 hours suffer
osmotic shock and die due to either necrosis or apop-
tosis, or both [30]. To test the effect of PBS, we cultured
HeLa cells in PBS and venom resuspended in PBS. We
observed cell death under both treatments (data not
shown). When venom was diluted in double-distilled
water as in other protocols, we did not observe any toxic
effects [10].
The most frequently reported cause of cell death
induced by crude or fractionated scorpion venom is
apoptosis, in which membrane receptors such as Fas-L
have been shown to be involved. This can activate the
extrinsic pathway of apoptosis and may also involve
caspases 8, 9 and 3 [10]. It has also been reported that
the venom elevates NO and RIN production, causes
depolarization of the mitochondria, releases pro-
apoptotic factors, and activates the intrinsic apoptosis
pathway [14,15]. In the present study, cell death by
apoptosis or lysis was not observed. However, apoptosis
was induced in positive control cells when treated with
the antineoplastic cyclophosphamide (Figure 3). Morpho-
logical changes such as cell shrinkage and loss of contact
with other cells were also observed, whereas BE-AO stai-
ning revealed chromatin condensation (Figure 4), which is
a typical feature of apoptosis [24,27].
The absence of a Cll-venom effect on HeLa cells could
be partially explained by the lack of specific membrane
targets, such as ion channel proteins, some of which areabsent in some cancer cells, which regulate gene expres-
sion of ion channels according to their needs [31].
Much has been reported regarding the resistance of
cancer cells to new drugs and treatments. However, one
of the most important features involves overexpression
of genes encoding proteins that block mechanisms and,
in turn, switch on the apoptotic death pathway. It has
been reported that HeLa cells over-express Bcl-2 and
XIAP molecules, which confer resistance against apop-
tosis [32]. It has also been shown that down-regulation
of XIAP sensitizes a cancer cell to apoptosis induced by
anticancer drugs [33].
BAX is another protein that plays an important role
in apoptosis. Human papilloma virus protein E6
degrades P53, and cannot activate the transcription of
BAX [34]. In normal cells, BAX forms heterodimers
with Bcl-2, resulting in viable cells. P53 stimulates tran-
scription of BAX and forms homodimers that activate
the cellular changes leading to apoptosis. In cancerous
cells, where P53 is not functional, the level of BAX is
not increased and as a result, cells do not start the
apoptosis pathway [35]. It has also been shown that the
use of ion channel blockers against K+ and Ca2+ may
inhibit the process that triggers the pathways for cell
death by apoptosis in some cell types [36]. Thus, it
could be possible that Cll venom possesses ion chan-
nel blockers that prevent activation of the signaling
pathway of the apoptotic cascade and stop cell death.
It has been reported that loss of K+ ions causes
depolarization of the membrane and forces entry of
Ca2+ ions that participate in the activation of caspases
and apoptosis [37].
Although our results demonstrate a toxic effect of
Cll on macrophages and not on HeLa cells, it is
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cells other than HeLa. Further studies of the effect of
Cll venom on different cancer cell lines should be
performed to assess its potential value as an antican-
cer agent.
Conclusions
Centruroides limpidus limpidus venom showed no nega-
tive effects on HeLa cell cultures, possibly due to the ab-
sence of specific-HeLa cell membrane target molecules
in the venom. We conclude that crude Cll venom is not
a promising candidate for treating cervical uterine can-
cer. However, prospective studies on other cancer cell
lines are needed to assess any anticancer properties in
Cll venom.
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